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Background: Multivessel disease (MVD) is present in the majority of ST Elevation Myocardial Infarction (STEMI) patients with cardiogenic shock 
(CS). We investigated the effect of multivessel primary percutaneous coronary intervention (PCI) versus culpritvessel-only PCI on 1-year mortality in 
patients with MVD and STEMI complicated with CS.
Methods: Between 1997 and 2005, 292 consecutive STEMI patients with CS were treated with primary PCI in our institution. Patients with MVD 
were identified based on the coronary angiogram. MVD was defined as the presence of at least one stenosis >50% in a non-infarct related coronary 
artery. Kaplan-Meier survival curves were constructed and tested for significance by the Log-Rank statistic.
Results: MVD was present in 161 patients (55%). Multivessel PCI was performed in 23% (n=37) of patients with MVD and STEMI with CS. Baseline 
demographic, clinical and treatment variables were comparable between patients treated with multivessel primary PCI and culpritvessel-only 
PCI, with one exception; patients treated with multivessel primary PCI significantly more often received glycoprotein IIb/IIIa inhibitors during the 
procedure. One-year mortality was comparable between patients in the multivessel PCI group and patients in the culpritvessel-only PCI group (60% 
vs 52%, respectively, p=0.45).
Conclusions: In patients with MVD and STEMI complicated with CS, multivessel primary PCI was not associated with a reduction in 1-year 
mortality.
